Anti-CHI3L1 antibody-conjugated liposomes are a novel drug delivery system for studying targeted therapy in glioma. CHI3L1 is a protein that is highly expressed in gliomas, and the binding of the antibody enables specific targeting and drug release. By conjugating the antibody with liposomes, there is a significant improvement in the bioavailability and intracellular uptake efficiency of the drug. This technology not only reduces the toxicity of the drug to normal cells but also helps to overcome drug resistance caused by the tumor microenvironment. Anti-CHI3L1 antibody-conjugated liposomes hold great clinical application potential in glioma research.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-3780z | Mouse Anti-CHI3L1 Recombinant Antibody (clone 42H3) | WB, ELISA | Mouse IgG2b, κ |
MOB-2482MZ | Recombinant Mouse Anti-Human CHI3L1 Antibody (clone BU5B4) | ELISA, IHC-P, WB | Mouse antibody |
VS-0723-WK86 | Human Anti-CHI3L1 Recombinant Antibody (VS-0723-WK86) | FC | Chimeric (rabbit/human) IgG1 |
VS3-WK1962 | Recombinant Rabbit Anti-Mouse CHI3L1 Capture Antibody (clone R79-6S-2) | ELISA | Rabbit IgG |
VS3-WK1963 | Recombinant Rabbit Anti-Mouse CHI3L1 Detection Antibody (clone R34-4Z-7) | ELISA | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY90. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.